Total Assets for Regeneron Pharmaceuticals (REGN)
According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported total assets is $40.56B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal AssetsSwitch metric
Latest period
$40.56B
YoY change
+7.4%
5Y CAGR
+18.8%
Peak year (2025)
$40.56B
Latest annual
$40.56B
Total Assets history chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
Total Assets history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Total Assets | YoY |
|---|---|---|---|---|
| 2025 | $40.56B | +7.4% | ||
| 2024 | $37.76B | +14.1% | ||
| 2023 | $33.08B | +13.2% | ||
| 2022 | $29.21B | +14.9% | ||
| 2021 | $25.43B | +48.2% | ||
| 2020 | $17.16B | +15.9% | ||
| 2019 | $14.81B | +26.2% | ||
| 2018 | $11.73B | +33.9% | ||
| 2017 | $8.76B | +25.7% | ||
| 2016 | $6.97B | +24.3% | ||
| 2015 | $5.61B | +44.9% | ||
| 2014 | $3.87B | +31.2% | ||
| 2013 | $2.95B | +41.8% | ||
| 2012 | $2.08B | +57.2% | ||
| 2011 | $1.32B | +21.5% | ||
| 2010 | $1.09B | +47.0% | ||
| 2009 | $741.20M | +10.6% | ||
| 2008 | $670.04M | -28.4% | ||
| 2007 | $936.26M | +60.0% | ||
| 2006 | $585.09M | +38.2% | ||
| 2005 | $423.50M | -10.5% | ||
| 2004 | $473.11M | -1.3% | ||
| 2003 | $479.56M | +22.5% | ||
| 2002 | $391.57M | -21.0% | ||
| 2001 | $495.40M | +137.9% | ||
| 2000 | $208.27M | +52.0% | ||
| 1999 | $137.00M | -12.7% | ||
| 1998 | $156.90M | -6.8% | ||
| 1997 | $168.40M | +22.4% | ||
| 1996 | $137.60M | +46.7% | ||
| 1995 | $93.80M | -0.4% | ||
| 1994 | $94.20M | -19.9% | ||
| 1993 | $117.60M | +20.1% | ||
| 1992 | $97.90M | -14.1% | ||
| 1991 | $114.00M | +348.8% | ||
| 1990 | $25.40M | — |
Total Assets values are taken from Regeneron Pharmaceuticals's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual total assets for Regeneron Pharmaceuticals (REGN) came in at $40.56B – grew 7.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Regeneron Pharmaceuticals total assets compounded at +18.8% per year, sustaining 17 straight years of year-over-year growth.
Across the available history, total assets reached its high of $40.56B in 2025 and its low of $25.40M in 1990.
Within Healthcare, Regeneron Pharmaceuticals (REGN) ranks 9th among 8 peers we track. The peer median for total assets is $135.41B.
Regeneron Pharmaceuticals Total Assets by Year
Regeneron Pharmaceuticals Total Assets 2025: $40.56B
Regeneron Pharmaceuticals total assets in 2025 was $40.56B, grew 7.4% from 2024. This figure represents the highest annual value in the available history.
Regeneron Pharmaceuticals Total Assets 2024: $37.76B
Regeneron Pharmaceuticals total assets in 2024 was $37.76B, grew 14.1% from 2023.
Regeneron Pharmaceuticals Total Assets 2023: $33.08B
Regeneron Pharmaceuticals total assets in 2023 was $33.08B, grew 13.2% from 2022.
Regeneron Pharmaceuticals Total Assets 2022: $29.21B
Regeneron Pharmaceuticals total assets in 2022 was $29.21B, grew 14.9% from 2021.
Regeneron Pharmaceuticals Total Assets 2021: $25.43B
Regeneron Pharmaceuticals total assets in 2021 was $25.43B.
See more financial history for Regeneron Pharmaceuticals (REGN).
Sector peers — Total Assets
Companies in the same sector as Regeneron Pharmaceuticals, ranked by their latest total assets.
| Company | Total Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $542.90B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $309.58B | Healthcare |
| Johnson & Johnson (JNJ) | $199.21B | Healthcare |
| Merck & Co., Inc. (MRK) | $136.87B | Healthcare |
| AbbVie Inc. (ABBV) | $133.96B | Healthcare |
| AstraZeneca PLC (AZN) | $114.07B | Healthcare |
| Eli Lilly and Company (LLY) | $112.48B | Healthcare |
| Amgen Inc. (AMGN) | $90.59B | Healthcare |
Frequently asked questions
What is Regeneron Pharmaceuticals's total assets?
- Latest reported total assets for Regeneron Pharmaceuticals (REGN) is $40.56B (period ending December 31, 2025).
How has Regeneron Pharmaceuticals total assets changed year-over-year?
- Regeneron Pharmaceuticals (REGN) total assets changed +7.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Regeneron Pharmaceuticals total assets?
- Regeneron Pharmaceuticals (REGN) total assets compound annual growth rate is +18.8% over the most recent 5 years available.
When did Regeneron Pharmaceuticals total assets hit its highest annual value?
- Regeneron Pharmaceuticals total assets reached its highest annual value of $40.56B in 2025.
What was Regeneron Pharmaceuticals total assets in 2024?
- Regeneron Pharmaceuticals (REGN) total assets in 2024 was $37.76B.
What was Regeneron Pharmaceuticals total assets in 2025?
- Regeneron Pharmaceuticals (REGN) total assets in 2025 was $40.56B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
REGN Overview
Company profile, financial tools, and key metrics
REGN Revenue Counter
Earns $454.81 every second. See per minute, hour, and day.
REGN Earnings Counter
Earns $142.85 per second net profit. See per minute, hour, and day.
REGN Economic Scale
Exceeds Rwanda's GDP. Compare with world economies.
REGN What If Invested
What if you had invested $1,000? See historical returns from any date.
REGN How It Makes Money
Discover visual breakdown of $14.34B in revenue — where it comes from and where it goes.
REGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
REGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
REGN Daily Price Character
Explosive · 47.1% historical win rate (green days). Streaks & record days.
REGN Buybacks
4.33% TTM buyback yield. Shareholder yield & SBC comparison.
REGN Dividend Profile
Yield: 0.52%. See full history.
REGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
REGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.